Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer
Status:
Unknown status
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
This study is to assess the efficacy and safety of Endostar combined with mFOLFOX6 in
untreated metastatic colorectal cancer patients, and to find the markers that may predict the
efficacy.
Phase:
Phase 2
Details
Lead Sponsor:
Zhejiang Cancer Hospital
Treatments:
Endostar protein Folic Acid Leucovorin Levoleucovorin Oxaliplatin